Trial Profile
Clinical Trials Insight: 700024137
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2007
Price :
$35
*
At a glance
- Drugs Glycoside apoptosis inducer-alpha fetoprotein complex (Primary)
- Indications Cancer metastases; Colorectal cancer
- Focus Adverse reactions
- Sponsors Constab Pharmaceutical
- 26 Jun 2007 New trial record.